Invisible Shield QuickFire Challenge
Up to $200,000 in funding
Awardee
|
大学。密歇根州/塔扎aya Taza Aya specializes in non-thermal plasmas used to sterilize or deodorize ventilation air across a range of industries and applications. |
Overview
呼吸道病原体无处不在。尽管看不见它们，但它们会大大影响个人和社区。我们如何更好地保护自己免受这些无形威胁的侵害？该解决方案可能是“无形的盾牌”。病原体保护的未来可以超越传统的呼吸设备，以无缝整合到我们的日常生活中，成为抵抗疾病的“无形盾牌”。
As a follow-up to the重新构想呼吸保护Quickfire挑战, the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services and Johnson & Johnson Innovation – JLABS, working with Janssen Research & Development, LLC, are proud to introduce theInvisible Shield QuickFire Challenge。Innovators are invited to submit ideas for potential solutions that repel and protect against airborne viruses while integrating seamlessly into everyday life.
The innovator(s) with the best idea will be awarded up to $200,000 in funding from BARDA, access to the Johnson & Johnson Innovation – JLABS ecosystem, and support in developing their ideas from BARDA for one year, to support health security products and technologies in biotechnology, life science research, and medical innovations as they navigate research, development, and regulatory pathways.
Rewards and Benefits
- Up to two innovators will be awarded up to $200,000 in funding from BARDA
- 约翰从BARDA和专家指导on & Johnson Family of Companies for one year
- 访问Johnson＆Johnson Innovation -JLABS生态系统
我们在寻找什么
This Challenge seeks potential solutions that have an intended use to provide protection for individuals and communities from respiratory pathogens, including airborne viruses.Proposed technologies that solely provide protection against industrial or environmental factors, particularly air pollution, will not be considered in this Challenge.
包含或描述前进道路以满足以下任何标准的建议是首选但不是必需的。请记住，不要太大或太早以供考虑。Applications that clearly describe a concept or path forward to achieve these goals will also be considered during evaluation. The ideal potential solution would have the following characteristics:
- 适合所有人群和年龄
- Effective in preventing infection
- 不引人注目
- Easily integrates into daily life
- 简单，不需要特殊说明
- Safe, non-toxic to humans and animal life
- 每次使用便宜或低成本
Application process
解决方案将由审阅者和法官小组评估其满足以下标准的能力：
- Novelty
- Potential Impact
- 可行性/实用性
- 团队和资源的质量
- 计划使用资金
- 计划的清晰度：里程碑和定义的go/no go决定
Why this Challenge matters to us
在Johnson＆Johnson Innovation，我们认为一个好主意可以来自任何地方，我们的目标是找到旨在为世界各地患者提供解决方案的新技术。共同努力，我们可以激发下一个可能改变健康轨迹的好主意。
常见问题解答
如果我在访问门户网站时遇到麻烦怎么办？
确保您的浏览器是最新的，并接受cookie。您可以通过[email protected]if you are having technical difficulties as well.
Can I submit supporting documents (for example a video) as part of my application?
You will have the opportunity and are encouraged to upload supporting materials such as slide decks, research papers, and videos as part of your application. You may submit a video along with your typed responses. Maximum length is 2 minutes.
Is it ok if some of the information I submit is confidential?
不要提交机密信息。仅应提交非固定信息，并且您提交的任何内容都将被视为非机密。
What happens with IP (Intellectual Property)?
As this is a no strings attached arrangement, JLABS does not acquire any IP. Any IP creation and/or protection remains the sole responsibility of the inventors.
是否需要申请专利？
No, a patent is not required to apply. However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.
What kind of science / technology is appropriate for the Challenges?
We encourage all to apply. Find out more about what areas we desire to explore here:https://www.jnjinnovation.com/partnering
Who is eligible to apply?
Each Challenge has its own terms & conditions that can be found prior to filling out the application.
哪些标准将用于评估应用程序？
Applications will be evaluated by a panel of independent reviewers and judges on their ability to meet the following criteria:
- 想法的独特性
- Potential impact on human health
- Identification of key resources and plan to further idea
Who can I contact if I have questions about the Challenge or the application process?
请联系[email protected]with any questions.
Timeline
关于巴达
The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID). BARDA supports the transition of medical countermeasures such as vaccines, drugs, diagnostics, and devices from research through advanced development towards consideration for approval by the FDA and inclusion into the Strategic National Stockpile. BARDA’s support includes funding, technical assistance, and core services. To date, BARDA has supported 50 FDA approvals for 45 unique products addressing CBRN, PI, and EID threats.
关于约翰逊和约翰逊的詹森制药公司
在约翰逊和约翰逊的詹森制药公司，我们正在努力创造一个没有疾病的世界。通过寻找新的更好的方法来改变生活预防，拦截，治疗和治愈疾病激发了我们。我们将最好的头脑汇集在一起and pursue the most promising science.
We are Janssen. We collaborate with the world for the health of everyone in it. Learn更多www.janssen.com。跟随我们@JanssenGlobal。
About Johnson & Johnson Innovation
强生公司创新,公司专注于accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation – JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit:www.jnjinnovation.com.
关于Johnson＆Johnson Innovation -Jlabs
Johnson & Johnson Innovation-JLABS（JLABS）是一个全球开放创新生态系统的网络，在广泛的医疗保健范围内促进并赋予创新者，包括药品，医疗设备，消费者和健康技术领域，以创建和加速生命，生命增强，生命增强健康，健康和保健的健康，保健和保健，保健和保健，保健和保健健康，保健和保健技术领域。对世界各地患者的解决方案。JLABS通过为新兴公司提供最佳环境来实现这一点明天的突破性医疗解决方案。在JLABS，我们重视伟大的想法，并热衷于消除成功的障碍，以帮助创新者释放其早期科学发现的潜力。JLABS是一个无弦的模型，这意味着企业家可以在坚持其知识产权的同时自由发展科学。JLABS还发表了运动，以寻找名为Quickfire挑战的最佳科学。乐动体育为什么赞助西甲有关更多信息，请访问www.www.2574design.comor follow@JLABS。